SoftBank Vision Fund — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Neumora is a clinical research company developing investigational medications, with a focus on conducting clinical trials to obtain regulatory approval and make treatments available to patients.
BiotechDeep TechDigital HealthMedical DevicesWatertown, US
Joshua Pinto(Executive Officer)Tamara Tompkins(Executive Officer)inKari Stefansson(Director)Maykin Ho(Director)Alaa Halawa(Director)
BoardKristina Burow(Director)in
Co-investorsARCH Venture PartnersCatalio Capital Management, LPF-Prime CapitalK2 HealthVenturesMercury FundPremier Partners+2 more
insitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines.
AI & Machine LearningBiotechSouth San Francisco, US
Daphne Koller(CEO & Founder)inDuane Valz(General Counsel)inMary Rozenman(Chief Financial Officer)in
BoardRobert Nelsen(Director)Vijay Pande(Director)in
Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalGV (Google Ventures)HOF CapitalBezos Expeditions+5 more
REEF converts underused parking lots and garages into neighborhood hubs hosting ghost kitchens, delivery, retail and healthcare.
Miami, US
Ari Ojalvo(Executive Officer, Director)Adan Gossar(Executive Officer)inCarl Segal(Executive Officer)Jillian Hunt(Executive Officer)inDavid Kownator(Executive Officer)inMatt Lindenberger(Executive Officer)in
Co-investorsBY Venture PartnersLDR VenturesTarget GlobalWamda Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.